Metabolism of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by liver homogenate fractions

Authors:
  • JWJeff Weissman
    Jeff Weissman
  • ATAnthony Trevor
    Anthony Trevor
  • KCKan Chiba
    Kan Chiba
  • PCPatricia Caldera
    Patricia Caldera
  • NCNeal Castagnoli
    Neal Castagnoli
  • TBThomas Baillie
    Thomas Baillie

Abstract
The piperideine derivative 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a thermal breakdown product of the abused narcotic analgetic agent 1-methyl-4-phenyl-4-(propionyloxy)-1,2,3,6-tetrahydropyridine has been reported to cause a clinical syndrome indistinguishable from idiopathic Parkinson''s disease in man and to destroy selectively the nigrostriatal system in monkeys. The metabolic fate of the nigrostriatal toxin-1-MPTP was examined in rat and rabbit liver mitochondrial and rabbit liver microsomal preparations. The mitochondrial preparations rapidly oxidized MPTP, in a pargyline-sensitive reaction, to a polar material that contained the 1-methyl-4-phenylpyridinium species as the principal product. NADPH-supplemented microsomal preparations converted MPTP to 2 principal products: 2 and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine N-oxide. CO and SKF 525A [proadifen hydrochloride] selectively inhibited the oxidation of MPTP to the nor compound, indicating that this N-demethylation reaction is cytochrome P-450 catalyzed. Attempts to trap possible unstable iminium metabolites of MPTP in microsomal incubation mixtures with sodium cyanide led to the isolation of a monocyano adduct that proved to be the N-cyanomethyl derivative. Hepatic mitochondrial and microsomal enzyme systems evidently catalyze the oxidation of MPTP by different pathways, the former leading to the generation of species that may possess neurotoxic properties.

This publication has 11 references indexed in Scilit: